Cullinan Therapeutics (CGEM) Other Non Operating Income (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly Other Non Operating Income came in at -$62000.0 in Q1 2026, up 27.06% year-on-year from -$48796.3 in Q1 2025, and up 10.14% quarter-over-quarter from -$69000.0 in Q4 2025.
Cullinan Therapeutics (CGEM) Other Non Operating Income (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$62000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 27.06% year-over-year to -$62000.0 in Q1 2026; TTM through Mar 2026 was -$420000.0, a 75.0% decrease from a year earlier, with the FY2025 full-year figure at -$443000.0, down 122.61% from the prior year.
- Other Non Operating Income advanced to -$62000.0 in Q1 2026 per CGEM's latest filing, from -$69000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $298000.0 in Q4 2022 and bottomed at -$241000.0 in Q2 2022.
- The 5-year median for Other Non Operating Income is -$69000.0 (2025), against an average of -$27200.0.
- Biggest YoY gain for Other Non Operating Income was 7350.0% in 2022; the steepest drop was 2912.5% in 2022.
- Year by year, Other Non Operating Income stood at $298000.0 in 2022, then plunged by 139.26% to -$117000.0 in 2023, then jumped by 105.13% to $6000.0 in 2024, then sank by 1250.0% to -$69000.0 in 2025, then climbed by 10.14% to -$62000.0 in 2026.
- Per Business Quant, the three latest CGEM Other Non Operating Income figures stand at -$62000.0 (Q1 2026), -$69000.0 (Q4 2025), and -$108000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -69,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -181,000.00 |
| Mar 31, 2025 | -85,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Mar 31, 2024 | -44,000.00 |
| Dec 31, 2023 | -117,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 69,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 298,000.00 |
| Jun 30, 2022 | -241,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -8,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -12,000.00 |